Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Keratin 19 monoclonal antibody (2F8)

 
ADI-905-839-100 100 µl 330.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:KRT19
 
Clone:2F8
 
Host:Mouse
 
Isotype:IgG1
 
Immunogen:Recombinant human CK19 (keratin 19) (aa 240-390).
 
UniProt ID:P08727
 
Species reactivity:Human
 
Applications:WB
 
Recommended Dilutions/Conditions:Western Blot (1:2500)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Application Notes:Detects a band of ~44kDa (full length) by Western blot.
 
Purity Detail:Protein G affinity purified.
 
Formulation:Liquid. In PBS, pH 7.3, containing 1% BSA, 50% glycerol and 0.02% sodium azide.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Scientific Background:Keratin 19 belongs to the keratin family of intermediate filament proteins responsible for the structural integrity of epithelial cells, subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins arranged in pairs of heterotypic keratin chains.  Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells, but specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis.
 
Keratin 19 monoclonal antibody (2F8) Western blot
Western blot analysis of HepG2 cell lysate probed with Keratin 19 mAb (2F8) at 1:2500.
Please mouse over
Keratin 19 monoclonal antibody (2F8) Western blot

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Cytokeratin
By biological activity:
Cytokeratin Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,